4.4 Article

MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Anticancerous potential of polysaccharides sequentially extracted from Polygonatum cyrtonema Hua in Human cervical cancer Hela cells

Ling Li et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Review Medical Laboratory Technology

Potential of nano-phytochemicals in cervical cancer therapy

Neera Yadav et al.

CLINICA CHIMICA ACTA (2020)

Article Biotechnology & Applied Microbiology

miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3

Gang Zhao et al.

ONCOTARGETS AND THERAPY (2019)

Article Genetics & Heredity

microRNA-143 acts as a suppressor of hemangioma growth by targeting Bcl-2

Chongqing Huang et al.

Article Health Care Sciences & Services

The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis

Jinyun Li et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)

Article Multidisciplinary Sciences

Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration

M. Kasim Diril et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Anatomy & Morphology

Maternally imprinted microRNAs are differentially expressed during mouse and human lung development

Andrew E. Williams et al.

DEVELOPMENTAL DYNAMICS (2007)